Elevara Medicine
London
About Elevara Medicine
Elevara Medicines addresses a basic issue in rheumatoid arthritis (RA): individuals who fail to achieve disease remission using immune-targeted therapies. Elevara Medicines intends to breach the efficacy barrier that patients face with current immunosuppressive medications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $70.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2025)
- Website: elevara.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/elevara-medicine-87007 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.